OR WAIT null SECS
November 12, 2021
Fujifilm is expanding its R&D footprint at its California facility.
Baxter will invest $100 million in new lyophilization equipment and an additional aseptic syringe filling line at its Halle/Westfalen (Germany) location.
Sotera’s acquisition of Regulatory Compliance Associates (RCA) will expand its technical consulting services.
AbbVie will pay REGENXBIO up to $1.75 billion for the rights to develop and commercialize its treatment of various eye conditions.
European Medicines Agency (EMA) granted Rafael’s CPI-613 (devismat) an orphan drug designation for the treatment of refractory or relapsed Burkin’s lymphoma.
November 11, 2021
The agency is recommending the authorization of Ronapreve (casirivimab/imdevimab) and Regkirona (regdanvimab), two monoclonal antibody drugs, for treating COVID-19.
Hovione will invest $170 million in new capacity and capabilities in Portugal, Ireland, and New Jersey
November 10, 2021
The agency is evaluating Moderna’s application for use of Spikevax in children aged 6 to 11.
The winners of the 18th CPhI Pharma Awards, which are given as a recognition of ‘Excellence in Pharma’, were announced on November 9, 2021, in Milan.
Part 2—Industry experts from MilliporeSigma, Lonza, Astrea Bioseparations, and Sartorius provide insight and examples about solving critical challenges in both analytics and process development for emerging therapies.